Literature DB >> 9259194

Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease.

K J Friedman1, R A Heim, M R Knowles, L M Silverman.   

Abstract

The CFTR intron 8 variable length polythymidine tract modulates the cystic fibrosis (CF) phenotype associated with the mutation R117H. To explore whether other mutations reside on multiple intron 8 backgrounds with discernible impacts on phenotype, we developed an allele-specific PCR assay to characterize this locus. Our approach types samples rapidly without the use or radioisotopes. Polythymidine alleles were identified for mutations either associated with a wide range of clinical phenotypes (R117H, R347P, G85E, D1152H, R334W, 2789 + 5 G > A, 3849 + 10kb C > T), and/or located at hypermutable CpG loci (R117H, 3845 + 10kb C > T, R553X, R334W, S945L and R75Q). R117H was detected in cis with each of three alleles (5T, 7T, 9T) at the intron 8 locus. The novel R117H-9T association was detected in a 10-month African-American male with borderline-to-mildly elevated sweat chloride values (approximately 50-66 mEq/L). All other mutations studied were associated with 7T except 3849 + 10kb C > T, which was detected on both 7T and 9T backgrounds, but not 5T. Three individuals with a delta F508/3849 + 10kb C > T genotype were 9T,9T and had pancreatic sufficiency and normal sweat chloride values, whereas 15 others who carried 3849 + 10kb C > T on a 7T background had variable pancreatic function (sufficient, n = 12, insufficient, n = 3), and variable sweat chloride values (normal, n = 12, elevated, n = 3). Surprisingly, when not associated with known CFTR mutations, 5T was detected with elevated frequency among individuals with sinopulmonary disease of ill-defined etiology, but with some characteristics of variant CF. In summary, the 5T allele was not found in cis with CF-causing mutations besides R117H, but an elevated 5T allele frequency in variant CF patients suggests 5T may be associated with disease in some situations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259194     DOI: 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.0.CO;2-G

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  Cystic fibrosis in adults: current and future management strategies.

Authors:  Brian M Morrissey; Bettina C Schock; Gregory P Marelich; Carroll E Cross
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

2.  Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene.

Authors:  Genevieve Pont-Kingdon; Mohamed Jama; Christine Miller; Alison Millson; Elaine Lyon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.

Authors:  Tester F Ashavaid; Altaf A Kondkar; Alpa J Dherai; Rani Raghavan; Soonu V Udani; Zarir F Udwadia; Devendra Desai
Journal:  Mol Diagn       Date:  2005

4.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

Review 5.  Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.

Authors:  Samuel M Moskowitz; Ronald L Gibson; Eric L Effmann
Journal:  Pediatr Radiol       Date:  2005-05-03

6.  Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis.

Authors:  S Kimura; Y Okabayashi; K Inushima; Y Yutsudo; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

7.  Response to Nogales-Gadea et al.

Authors:  Mauricio De Castro; Leslie G Biesecker
Journal:  Genet Med       Date:  2015-08       Impact factor: 8.822

8.  Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.

Authors:  Morten Dahl; Anne Tybjaerg-Hansen; Peter Lange; Børge G Nordestgaard
Journal:  Respir Res       Date:  2005-10-09

9.  Survey of CF mutations in the clinical laboratory.

Authors:  Klaus Huber; Borka Mirkovic; Rhea Nersesian; Angela Myers; Randall Saiki; Kurt Bauer
Journal:  BMC Clin Pathol       Date:  2002-11-19

Review 10.  Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR?

Authors:  M P Boyle
Journal:  Respir Res       Date:  2000-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.